
Ghanshyam Jaju Converts 60,000 Warrants to Shares
Ghanshyam Jaju, Director of Godavari Drugs Limited, has disclosed the conversion of 60,000 convertible warrants into 60,000 equity shares. This transaction resulted in a change in his shareholding. Before the conversion, his total holding was 120,000 shares (0.96% of total capital) and 530,000 warrants (3.76% of total capital), totaling 4.24% of diluted capital. After the conversion, his shareholding increased to 470,000 shares, while his warrant holding decreased to 60,000 (0.48% of total capital). The total transaction involved 60,000 equity shares, representing a 0.51% change in voting rights and a 0.48% change in diluted capital. The conversion was an allotment of equity shares upon conversion of warrants on November 17, 2026.
Key Highlights
- Ghanshyam Jaju converted 60,000 warrants into equity shares.
- His shareholding increased by 60,000 shares.
- The transaction represents a 0.51% change in voting rights.
- The conversion impacts diluted shareholding by 0.48%.
Price Impact
More from GODAVARI